Outpatient management of diabetic patients with a history of the acute coronary syndrome - Summary of recommendations and evidence
An HbA1c target < 7% should be used in most diabetic patients to reduce microvascular events.	I	A
The HbA1c target must be individualized, considering characteristics such as comorbidities, life expect,ancy and the duration of DM	I	C
Unless contraindicated, metformin is the drug of choice for initial DM treatment.	I	A
After ACS, consider combined treatment including an SGLT2 inhibitor or a GLP1-RA with proven cardiovascular benefits regardless of HbA1c level.	I	A
In patients with HF or nephropathy (creatinine clearance between 30 and 90 mL/min and/or with proteinuria), SGLT2 inhibitors are the drug of choice.	I	A
Use saxagliptin and pioglitazone in diabetic patients with HF.	III	A